A recent study has demonstrated a significant decrease in cases of human papilloma virus infection in England since the introduction of a bivalent vaccine in 2008.
Through a process of elimination, researchers have identified membrane surface proteins on T. pallaidum, which can be targeted by immune antibodies.
Following a five decade-long battle against malaria, Paraguay has received certification from the WHO as having eliminated the disease.
Whole-genome sequencing has been used to demonstrate that carbapenem resistance can be transferred among unrelated bacteria species in a healthcare setting.
At ASM Microbe GeoVax have spoken on the development of single-dose vaccines for emerging diseases using their MVA ‘Plug and Play’ platform technology.
New research indicates that false negative RIAT results could delay antiviral therapy for half of patients admitted to intensive care units.
Research presented at ASM Microbe has revealed that Treg cells may be protecting babies from contracting HIV from their mothers in utero.
Researchers demonstrate for the first time the importance of bacteriophages in the development of multifactorial diseases such as Parkinson’s, a potentially critical factor that has been previously over-looked.